SeaStar Medical Holding Corp. Files 8-K on Shareholder Vote Matters

TL;DR

SeaStar Medical Holding Corp. had a shareholder vote on June 4th, details to follow.

AI Summary

SeaStar Medical Holding Corp. filed an 8-K on June 4, 2024, to report on matters submitted to a vote of its security holders. The filing does not contain specific details about the proposals voted on or the outcome of the vote.

Why It Matters

This filing indicates that SeaStar Medical Holding Corp. held a shareholder vote, which could relate to significant corporate actions or governance changes.

Risk Assessment

Risk Level: low — The filing is a routine procedural report and does not disclose new financial information or material events that would immediately impact risk.

Key Players & Entities

• SeaStar Medical Holding Corp. (company) — Registrant
• June 04, 2024 (date) — Date of earliest event reported
• Delaware (jurisdiction) — State of Incorporation
• 001-39927 (filing_id) — SEC File Number
• 85-3681132 (tax_id) — IRS Employer Identification No.
• 3513 Brighton Blvd, Suite 410 (address) — Principal Executive Offices
• Denver, Colorado 80216 (location) — Principal Executive Offices Location

FAQ

Key Financial Figures

• $0.0001 — ich registered Common Stock par value $0.0001 per share ICU The Nasdaq Stock Mark
• $11.50 — sable for one share of Common Stock for $11.50 per share ICUCW The Nasdaq Stock Ma

Filing Documents

• icu-20240604.htm (8-K) — 80KB
• 0000950170-24-068696.txt ( ) — 226KB
• icu-20240604.xsd (EX-101.SCH) — 45KB
• icu-20240604_htm.xml (XML) — 6KB

07 Submission of Matters to a Vote of Security Holders

Item 5.07 Submission of Matters to a Vote of Security Holders. The special meeting of stockholders (the "Special Meeting") of SeaStar Medical Holding Corporation (the "Company") was held virtually on June 4, 2024 at 10:00 a.m., Mountain Time. The following proposals were approved by the stockholders, each by the votes set forth below: Proposal 1 . To elect three Class II Directors to serve until the 2027 annual meeting of stockholders, or until their successors shall have been duly elected and qualified: Nominee Votes For Votes Against Absentions Broker Non-Votes Allan Collins, MD 25,571,422 — 5,434,244 16,568,804 Jennifer A. Baird 29,954,851 — 1,050,815 16,568,804 Bernadette N. Vincent 29,950,656 — 1,055,010 16,568,804 Proposal 2. To approve an amendment and restatement of the Company's 2022 Omnibus Equity Incentive Plan (the "Plan") to increase the number of authorized shares of common stock ("Common Stock") from 3,278,457 to 9,778,457 Votes For Votes Against Absentions Broker Non-Votes 19,575,471 11,202,158 228,037 16,568,804 Proposal 3. To approve, for purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of 20% or more of the Company's outstanding shares of Common Stock upon exercise of Series A Warrants to purchase 10,840,761 shares of Common Stock and Series B Warrants to purchase 5,420,381 shares of Common Stock pursuant to the terms of the Securities Purchase Agreement with a single institutional investor: Votes For Votes Against Absentions Broker Non-Votes 23,754,015 6,692,280 559,371 16,568,804 Proposal 4. To ratify the appointment of WithumSmith+Brown, PC as our independent registered public accounting firm for the fiscal year ending December 31, 2024: Votes For Votes Against Absentions Broker Non-Votes 44,584,985 1,831,139 1,158,346 —

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SeaStar Medical Holding Corporation By: /s/ Eric Schlorff Date: June 4, 2024 Name: Eric Schlorff Title: Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR